The consensus from the current study deviates from this guidance, recommending primary care HCPs proactively discuss prostate cancer risk, PSA testing, and the wider diagnostic pathway with men aged ≥45 years at higher-than-average risk (that is, Black ethnicity or family history of prostate cancer, or confirmed genetic risk factors). Here, KLK3 is linked to prostate carcinoma.